JPRN-jRCT2080222625
Unknown
Phase 3
A phase 3 clinical trial of duloxetine in patients with osteoarthritis
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shionogi & Co., Ltd.
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants meet the ACR criteria for idiopathic osteoarthritis of the knee.
Exclusion Criteria
- •Participants with past history of multiple episodes of drug allergy.
- •Participants previously treated with duloxetine.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 3
A phase 3 clinical trial of duloxetine in patients with chronic low back paiChronic low back painJPRN-jRCT2080222083SHIONOGI & CO., LTD.
Unknown
Phase 3
A Phase III Clinical Trial of Duloxetine in Participants With FibromyalgiaFibromyalgiaJPRN-jRCT2080221737SHIONOGI & CO., LTD.
Completed
Phase 3
A phase 3 clinical trial of duloxetine in children and adolescents with depressive disorderJPRN-jRCT2080223678Shionogi & Co., Ltd.149
Unknown
Phase 4
A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic PaiDiabetic Peripheral Neuropathic PainJPRN-jRCT1080222824Shionogi & Co., Ltd.
Completed
Phase 3
A Study of Duloxetine in FibromyalgiaFibromyalgiaNCT01552057Eli Lilly and Company393